{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:20:52Z","timestamp":1783146052440,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LJHSQY26H030001"],"award-info":[{"award-number":["LJHSQY26H030001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008092","name":"Jinhua City Science and Technology Bureau","doi-asserted-by":"publisher","award":["2021-4-030"],"award-info":[{"award-number":["2021-4-030"]}],"id":[{"id":"10.13039\/501100008092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.dld.2026.04.019","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:30:22Z","timestamp":1778959822000},"page":"919-924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repeated intravenous weight-based ustekinumab maintenance as an optimization strategy for Crohn\u2019s disease patients with loss of response to standard therapy"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0865-5023","authenticated-orcid":false,"given":"Chong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10432","key":"10.1016\/j.dld.2026.04.019_bib0001","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","article-title":"Crohn\u2019s disease","volume":"403","author":"Dolinger","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.dld.2026.04.019_bib0002","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/ecco-jcc\/jjz158","article-title":"The role of Immunomodulators and biologics in the medical management of stricturing Crohn\u2019s Disease","volume":"14","author":"Rodr\u00edguez-Lago","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.dld.2026.04.019_bib0003","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.dld.2026.04.019_bib0004","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/apt.14030","article-title":"Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn\u2019s disease and ulcerative colitis controlled trials","volume":"45","author":"Cholapranee","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.dld.2026.04.019_bib0005","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment","volume":"18","author":"Gordon","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.dld.2026.04.019_bib0006","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ecco-jcc\/jjz110","article-title":"IM-UNITI: three-year efficacy, safety, and immunogenicity of ustekinumab treatment of Crohn\u2019s Disease","volume":"14","author":"Hanauer","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"9","key":"10.1016\/j.dld.2026.04.019_bib0007","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/14712598.2025.2556909","article-title":"Long-term effectiveness and safety of ustekinumab in patients with Crohn\u2019s disease: real-world evidence","volume":"25","author":"Wu","year":"2025","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.dld.2026.04.019_bib0008","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/MIB.0000000000001074","article-title":"Long-term maintenance of clinical, endoscopic, and radiographic response to ustekinumab in moderate-to-severe Crohn\u2019s disease: real-world experience from a multicenter cohort study","volume":"23","author":"Ma","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.dld.2026.04.019_bib0009","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ecco-jcc\/jjz080","article-title":"Long-term clinical effectiveness of ustekinumab in patients with Crohn\u2019s disease who failed biologic therapies: a national cohort study","volume":"13","author":"Liefferinckx","year":"2019","journal-title":"J Crohns Colitis"},{"issue":"12","key":"10.1016\/j.dld.2026.04.019_bib0010","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.cgh.2021.10.002","article-title":"Effectiveness of reinduction and\/or dose escalation of ustekinumab in Crohn\u2019s disease: a systematic review and meta-analysis","volume":"20","author":"Meserve","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2026.04.019_bib0011","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1007\/s10620-023-07822-7","article-title":"Ustekinumab trough concentrations are associated with biochemical outcomes in patients with Crohn\u2019s disease","volume":"68","author":"Straatmijer","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.dld.2026.04.019_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11938-019-00222-9","article-title":"Advances in therapeutic drug monitoring for small-molecule and biologic therapies in inflammatory bowel disease","volume":"17","author":"Ma","year":"2019","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2026.04.019_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13051519","article-title":"Ustekinumab in the treatment of inflammatory bowel diseases: evolving paradigms","volume":"13","author":"Mocci","year":"2024","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.dld.2026.04.019_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103410","article-title":"Immune-mediated inflammatory diseases: common and different pathogenic and clinical features","volume":"22","author":"Monteleone","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.dld.2026.04.019_bib0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10620-023-08182-y","article-title":"Dual-targeted therapy with upadacitinib and ustekinumab in medically complex Crohn\u2019s disease","volume":"69","author":"Miyatani","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.dld.2026.04.019_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/biom15020222","article-title":"Dual therapy in inflammatory bowel disease","volume":"15","author":"Altieri","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.dld.2026.04.019_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109545","article-title":"Combination therapy in inflammatory bowel disease: current evidence and perspectives","volume":"114","author":"Dai","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.dld.2026.04.019_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1105981","article-title":"Extra intravenous ustekinumab reinduction is an effective optimization strategy for patients with refractory Crohn\u2019s disease","volume":"10","author":"Yao","year":"2023","journal-title":"Front Med"},{"issue":"8","key":"10.1016\/j.dld.2026.04.019_bib0019","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ibd\/izad184","article-title":"Efficacy of ustekinumab optimization by 2 initial intravenous doses in adult patients with severe Crohn\u2019s disease","volume":"30","author":"Ren","year":"2024","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.dld.2026.04.019_bib0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000543831","article-title":"Efficacy of dose escalation of ustekinumab in inflammatory Bowel disease: a systematic review and meta-analysis","volume":"34","author":"Rehman","year":"2025","journal-title":"Med Princ Pract"},{"issue":"7","key":"10.1016\/j.dld.2026.04.019_bib0021","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.cgh.2020.07.064","article-title":"Intravenous ustekinumab reinduction is effective in prior biologic failure Crohn\u2019s disease patients already on every-4-week dosing","volume":"19","author":"Sedano","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.dld.2026.04.019_bib0022","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.cgh.2021.10.002","article-title":"Effectiveness of reinduction and\/or dose escalation of ustekinumab in Crohn\u2019s disease: a systematic review and meta-analysis","volume":"20","author":"Meserve","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2026.04.019_bib0023","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/ibd\/izae152","article-title":"Long-term outcomes of intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing","volume":"31","author":"Arg\u00fcelles-Arias","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.04.019_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231191670","article-title":"Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing","volume":"16","author":"Arg\u00fcelles-Arias","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"issue":"14","key":"10.1016\/j.dld.2026.04.019_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11144202","article-title":"Real-world evidence of the effectiveness and safety of ustekinumab for the treatment of Crohn\u2019s disease: systematic review and meta-analysis of observational studies","volume":"11","author":"Rub\u00edn de C\u00e9lix","year":"2022","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.dld.2026.04.019_bib0026","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.gastrohep.2022.10.016","article-title":"Relationship between ustekinumab trough concentrations and both clinical and biological remission in patients with Crohn\u2019s disease","volume":"46","author":"Lao Dom\u00ednguez","year":"2023","journal-title":"Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.dld.2026.04.019_bib0027","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/ibd\/izaa282","article-title":"Predictors of ustekinumab failure in Crohn\u2019s disease after dose intensification","volume":"27","author":"Dalal","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.dld.2026.04.019_bib0028","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.crohns.2011.10.010","article-title":"Profiles of circulating cytokines in patients with Crohn\u2019s disease under maintenance therapy with infliximab","volume":"6","author":"Ogawa","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"8","key":"10.1016\/j.dld.2026.04.019_bib0029","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ibd\/izad184","article-title":"Efficacy of ustekinumab optimization by 2 initial intravenous doses in adult patients with severe Crohn\u2019s disease","volume":"30","author":"Ren","year":"2024","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.dld.2026.04.019_bib0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cgh.2020.02.035","article-title":"Effectiveness of ustekinumab dose escalation in patients with Crohn\u2019s disease","volume":"19","author":"Ollech","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.04.019_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820959245","article-title":"Ustekinumab dose escalation improves clinical responses in refractory Crohn\u2019s disease","volume":"13","author":"Haider","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2026.04.019_bib0032","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231191670","article-title":"Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing","volume":"16","author":"Arg\u00fcelles-Arias","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2026.04.019_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastrohep.2024.502253","article-title":"Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and adjusted regimen in real world","volume":"48","author":"M\u00ednguez","year":"2025","journal-title":"Gastroenterol Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:01:49Z","timestamp":1783144909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826007267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1590865826007267"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.04.019","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated intravenous weight-based ustekinumab maintenance as an optimization strategy for Crohn\u2019s disease patients with loss of response to standard therapy","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}